Illumina's Q4 Revenues Grow 32 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that total fourth quarter 2014 revenues increased 32 percent year over year.

The San Diego-based company said that for the last three months of 2014, it took in $512.4 million in total revenues, up from $387.3 in the year ago quarter. Product revenues climbed 34 percent in the quarter to $450.3 million from $336.4 million in Q4 2013, while service revenue grew 22 percent to $62.1 million from $50.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.